miR-138-5p inhibits HIF-1α/VEGFA signaling and vascular mimicry in hepatocellular carcinoma and suppresses EMT/migration in breast cancer, indicating its anti-angiogenic role in multiple contexts [85]. Here, HIF1A is linked to breast carcinoma.